The United States does not simply have a shortage of cardiologists. It has a growing mismatch between what cardiologists are increasingly incentivized to do and what patients increasingly need them to do.

Across the healthcare system, cardiology is being reorganized around procedures. Between private equity-backed consolidation, ambulatory surgical center expansion, hospital employment models, and MSO roll-ups, more cardiologists are being pulled into procedural environments while fewer are focused on longitudinal disease management.

At exactly the same moment, the burden of chronic cardiovascular disease is exploding. Heart failure, atrial fibrillation, obesity-related cardiovascular disease, diabetes, and hypertension increasingly require continuous outpatient management, medication optimization, and proactive follow-up over years — not episodic intervention alone.

These trends are colliding in ways that should concern patients, physicians, health systems, and policymakers alike.

The central problem in ambulatory cardiology today is not simply workforce supply. It is workforce allocation.

Traditionally, ambulatory cardiology was organized around episodic office visits. Patients returned every three to six months, often regardless of clinical trajectory, with relatively limited ability to monitor or intervene between appointments. Even before today’s workforce pressures, that model was increasingly mismatched with the realities of chronic cardiovascular disease, which evolves continuously rather than intermittently.

But instead of redesigning care around longitudinal management, the economics of cardiology have increasingly reinforced procedural care delivery.

Within many health systems, cardiology is one of the most financially important service lines because of imaging, electrophysiology, catheterization, and downstream procedural referrals. Even organizations publicly committed to value-based care often remain economically dependent on fee-for-service procedural revenue.

That creates predictable incentives.

Investment flows toward cath labs, imaging centers, ambulatory surgical centers, and procedural recruitment. Meanwhile, infrastructure for chronic disease management — medication titration programs, care coordination, remote monitoring integration, and proactive outpatient management — remains comparatively underdeveloped.

The issue is not that procedures lack value. Many are lifesaving and transformative. The problem is that the healthcare system increasingly rewards intervention after disease progression more than the continuous management that may prevent deterioration in the first place.

Over time, those incentives shape how physician time gets allocated and what kinds of careers physicians choose to build.

Private equity has accelerated these dynamics. PE-backed cardiology platforms are often organized around procedural growth through ambulatory surgical centers and centralized management structures. From a business perspective, the logic is straightforward: procedures scale well, generate predictable revenue, and produce attractive margins.

But these structures also pull physician capacity toward procedural care environments and away from longitudinal ambulatory management.

At the same time, many senior cardiologists who built careers around office-based chronic disease management are retiring or reducing clinical workloads amid growing burnout and administrative burden. Younger physicians increasingly enter systems where procedural specialization is better compensated, more operationally supported, and often less administratively exhausting than continuous outpatient management.

What is gradually disappearing is not cardiology itself, but a particular kind of cardiologist: the physician primarily focused on longitudinal disease management.

That loss is occurring at exactly the wrong time.

The epidemiology of cardiovascular disease is moving in the opposite direction from workforce incentives. The U.S. population is aging. Obesity, diabetes, hypertension, and heart failure continue to rise. Patients increasingly require continuous medication management, behavioral reinforcement, monitoring, and coordination across years — not office visits every several months followed by reactive escalation after deterioration occurs.

Yet the ambulatory cardiology system remains poorly designed to deliver that kind of care at scale.

This challenge is often framed as a physician shortage problem. But the more immediate issue may be that too little cardiology workforce capacity is allocated toward continuous disease management in the first place.

Who is managing medication optimization between visits? Who is identifying worsening heart failure before hospitalization? Who is coordinating outpatient cardiovascular care across fragmented systems? Who is responsible for prevention and continuity?

Too often, the answer is effectively nobody.

Technology can help, but it is not the core solution. Virtual care, remote monitoring, and AI-assisted workflows may extend physician capacity and improve continuity. But without reimbursement models that meaningfully value longitudinal disease management, those tools risk becoming incremental add-ons to a system still fundamentally optimized for procedures.

The deeper issue is incentives.

If healthcare leaders genuinely want more continuous cardiovascular care, cardiologists must be paid to provide it. That means building reimbursement models that reward prevention, medication optimization, continuity, and hospitalization reduction — not simply procedural volume.

None of this requires abandoning procedural cardiology. Cardiovascular intervention remains one of the great successes of modern medicine. But the current balance no longer matches the realities of chronic disease.

The United States is steadily building a cardiovascular care system optimized for intervention while simultaneously facing an explosion of chronic illness that requires continuous management.

That tradeoff increasingly makes little sense.

Because ultimately, the question is not whether the country has enough cardiologists.

It is whether enough of them are being enabled — and incentivized — to manage chronic disease before patients deteriorate.